Biography
- Division:
- Division of Translational and Clinical Sciences – DTCS
- Review Branch:
- Basic Cancer Mechanisms and Therapeutics – BCMT
- Study Section:
- umor Evolution, Heterogeneity and Metastasis – TEHM
Dr. Stoica received her Ph.D. degree in chemistry from the Lombardi Cancer Center at Georgetown University, Washington, D.C., studying the role of vitamin D3 and growth factors on estrogen receptor (ER) regulation in breast cancer. As a postdoctoral fellow, she extended her studies to the role of the heavy metal cadmium, as well as other endocrine disruptors in the development of hormone-dependent cancers (breast and prostate). As an assistant professor, Dr. Stoica determined the cross talk between the phosphatidyl inositol 3-kinase (PI3-K)/the serine-threonine kinase Akt and ER signaling pathways in breast cancer. In addition to her 17 years of cancer research, Dr. Stoica also taught molecular biology, genetics in health and in disease, and biotechnology at the Health Studies Program of the School of Nursing at Georgetown. In 2008, Dr. Stoica moved to the National Cancer Institute as a scientific review officer and in 2025, she joined the Center for Scientific Review.
